Rebecca Pastorino

CO-41 | COMPARISON OF COAGULATION AND CHROMOGENIC METHODS IN PHARMACOKINETICS WITH EXTENDED HALF-LIFE FACTOR VIII

Background and Aims. Personalized prophylaxis is still considered the standard of care for severe hemophilia A. Replacement prophylaxis can now rely on extended half-life factor VIII concentrates (FVIII-EHL), very effective but difficult to monitor. For some of them, differences in Factor VIII levels are found using di...